Prestige Consumer Healthcare Inc. SEC filings PBH

Prestige Consumer Healthcare Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 6, 2008. Its latest annual report, Form ARS, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on March 31.

Prestige Consumer Healthcare Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Aug 14, 2026 Aug 10, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
8-K Current report
Material agreement, New debt
Jul 15, 2026 Jul 15, 2026
8-K/A Amended current report Jul 9, 2026 Jun 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 7, 2026 —
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Jul 6, 2026 Jun 30, 2026
8-K/A Amended current report Jun 30, 2026 Jun 12, 2026
ARS Annual report to shareholders Jun 29, 2026 Mar 31, 2026
DEF 14A Proxy statement Jun 29, 2026 Jun 29, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Other events
Jun 16, 2026 Jun 12, 2026
10-K Annual report May 14, 2026 Mar 31, 2026
4/A Ownership document May 14, 2026 May 2, 2026
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
May 13, 2026 May 13, 2026
4 Insider transaction May 12, 2026 May 11, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
144 Notice of proposed sale May 11, 2026 —
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 5, 2026
144 Notice of proposed sale May 7, 2026 —
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
144 Notice of proposed sale May 6, 2026 —
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
4 Insider transaction May 5, 2026 May 2, 2026
144 Notice of proposed sale May 5, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 20, 2026 Mar 19, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
10-Q Quarterly report Feb 5, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 5, 2026 Feb 5, 2026
4 Insider transaction Jan 29, 2026 Jan 6, 2026
3 Initial insider ownership Jan 29, 2026 Jan 6, 2026
4 Insider transaction Dec 2, 2025 Nov 28, 2025
144 Notice of proposed sale Dec 1, 2025 —
144 Notice of proposed sale Nov 28, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
ARS Annual report to shareholders Jun 27, 2025 Mar 31, 2025
DEF 14A Proxy statement Jun 27, 2025 Aug 5, 2025
4 Insider transaction May 9, 2025 May 7, 2025
4 Insider transaction May 9, 2025 May 7, 2025
4/A Ownership document May 9, 2025 May 5, 2025
4 Insider transaction May 9, 2025 May 7, 2025
4 Insider transaction May 9, 2025 May 7, 2025
10-K Annual report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2025 May 8, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 7, 2025 May 5, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
4 Insider transaction Mar 12, 2025 Mar 10, 2025
144 Notice of proposed sale Mar 10, 2025 —
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 3, 2025 —
4 Insider transaction Feb 13, 2025 Feb 11, 2025
144 Notice of proposed sale Feb 11, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
10-Q Quarterly report Feb 6, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 6, 2025 Feb 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 23, 2025 —
4 Insider transaction Jan 7, 2025 Jan 6, 2025
8-K Current report
Officer or director change
Jan 6, 2025 Jan 6, 2025
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
144 Notice of proposed sale Nov 19, 2024 —
4 Insider transaction Nov 19, 2024 Nov 18, 2024
144 Notice of proposed sale Nov 18, 2024 —
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2024 Nov 7, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Aug 7, 2024 Aug 6, 2024
4 Insider transaction Aug 7, 2024 Aug 6, 2024
4 Insider transaction Aug 7, 2024 Aug 6, 2024
4 Insider transaction Aug 7, 2024 Aug 6, 2024
4 Insider transaction Aug 7, 2024 Aug 6, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
3 Initial insider ownership Aug 7, 2024 Aug 5, 2024
ARS Annual report to shareholders Jul 5, 2024 Mar 31, 2024
DEF 14A Proxy statement Jul 5, 2024 Aug 6, 2024
PRE 14A Preliminary proxy statement Jun 24, 2024 Aug 6, 2024
10-K Annual report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 14, 2024 May 14, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 9, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
8-K Current report
Officer or director change
May 8, 2024 May 8, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction May 6, 2024 May 2, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 1, 2024 —
4 Insider transaction Feb 29, 2024 Feb 27, 2024
144 Notice of proposed sale Feb 28, 2024 —
144 Notice of proposed sale Feb 27, 2024 —
4 Insider transaction Feb 27, 2024 Feb 23, 2024
144 Notice of proposed sale Feb 26, 2024 —
144 Notice of proposed sale Feb 23, 2024 —
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
144 Notice of proposed sale Feb 15, 2024 —
144 Notice of proposed sale Feb 14, 2024 —
144 Notice of proposed sale Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 12, 2024 Feb 8, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
144 Notice of proposed sale Feb 8, 2024 —
10-Q Quarterly report Feb 8, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 8, 2024 Feb 8, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 19, 2024 —
8-K Current report
Material agreement, New debt
Dec 13, 2023 Dec 8, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2023 Nov 2, 2023
4 Insider transaction Sep 15, 2023 Sep 14, 2023
144 Notice of proposed sale Sep 14, 2023 —
4 Insider transaction Aug 9, 2023 Aug 8, 2023
144 Notice of proposed sale Aug 8, 2023 —
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
3 Initial insider ownership Aug 3, 2023 Aug 1, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 3, 2023 Aug 3, 2023
ARS Annual report to shareholders Jun 29, 2023 Dec 31, 2022
DEF 14A Proxy statement Jun 29, 2023 Aug 1, 2023
4 Insider transaction May 26, 2023 May 24, 2023
4/A Ownership document May 24, 2023 May 19, 2023
144 Notice of proposed sale May 24, 2023 —
4 Insider transaction May 22, 2023 May 19, 2023
144 Notice of proposed sale May 19, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PBH (NYSE)
Fiscal year ends
March 31
Headquarters
Tarrytown, NY
SEC filer status
Large accelerated filer
SEC CIK
1295947
Former names
Prestige Brands Holdings, Inc. (until Aug 10, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.